Developed & Manufactured by Biomedica
- Products
- By research area
- Bone Metabolism
- Cardiovascular
- Cell proliferation
- immunology
- Infectious disease
- Metabolic Disease
- Nephrology & Transplant
- Neurology
- Oncology
- Oxidative stress
- Toxicity
By product typeDeals of the month
Download biomedica product list
- Services
- ServicesDeals of the month
Our ELISAs:
designed for your clinical
& preclinical application developed & manufactured
byFeatured Products & Promotions
Bioactive Sclerostin ELISASpecific antibodies targeting the receptor binding region Rigorously validated for clinical samples according to FDA/ICH/EMEA guidelines Low sample volume - 20 µl of serum/plasma per wellLearn MoreFGF23 (C-terminal) Multi-Matrix ELISAOnly ELISA that can detect human FGF23 (C-terminal) in both serum and plasma samplesLearn MoreFREE soluble RANKL HS ELISAHigh sensitivity – measurable concentrations in healthy subjectsLearn MoreLatest News-
Plasma levels of Semaphorin 4D are decreased by adjuvant tamoxifen but not aromatase inhibitor therapy in breast cancer patients.8 May, 2019Göbel A. et al., J Bone Oncology, 2019; 16: 100237. Full publication. SEMAPHORIN 4D is a soluble and membrane-bound protein that plays important roles in physiologic processes such as vascular growth, tumor progression, and immune cell regulation. Related literature: The Role of Semaphorin 4D in Bone Remodeling and Cancer Metastasis. Lontos K et al., Front [...]
-
C-Type Natriuretic Peptide: Emerging Applications in Disorders of Skeletal Growth23 April, 2019C-type natriuretic peptide (CNP), a small peptide hormone, plays a crucial role in linear growth. The growth plate is a major contributor to circulating CNP products in the immature skeleton. Its bio-inactive aminoterminal propeptide (NTproCNP) is easily measurable in plasma, and levels reflect the rate of CNP biosynthesis. Plasma C-Type Natriuretic Peptide: Emerging Applications in [...]
-
C-type Natriuretic Peptides in Coronary Disease19 March, 2019Pricket TCR et al. show in their publication "C-Type Natriuretic Peptides in Coronary Disease" that "in contrast to the close association of NT-proBNP with cardiac function, and predictive value for outcome after myocardial infarction, plasma NT-proCNP is highly correlated with renal function and is an independent predictor of mortality and cardiac readmission in individuals with [...]
Events-
Biomedica @ ECTS Congress Budapest25 April, 2019May 11 – 14, 2019 Meet Biomedica Immunoassays at the ECTS Congress in Budapest - booth # 12 - to learn more about our soon to be launched new assay and to discuss your research projects!In addition to having a booth, we will present the following posters: Development and characterization of an extraction-free human CGRP [...]
-
Biomedica @ Osteoporoseforum St. Wolfgang23 April, 2019May 9 – 11, 2019 Meet Biomedica Immunoassays at the Osteoporoseforum in St. Wolfgang to learn more about our soon to be launched new assay and to discuss your research projects! intact FGF23 ELISA C-terminal FGF23 ELISA bioactive Slcerostin ELISA Useful links: Scientific Program
-
Biomedica @ WCO-IOF-ESCEO Paris5 April, 2019WORLD CONGRESS ON OSTEOPOROSIS, OSTEOARTHRITIS AND MUSCULOSKELETAL DISEASES April 4 – 7, 2019 Meet Biomedica Immunoassays at poster P676 “Novel ELISA Allows Accurate Quantification of Intact Fibroblast Growth Factor 23 (FGF23) in Serum and Plasma” to learn more about our soon to be launched new assay and to discuss your research projects! Useful links: Scientific [...]